Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Billiontoone Inc's Competitiveness

Name: Billiontoone Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Billiontoone Inc (BLLN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

vs 100.00 % a year ago

Revenue Growth Y/Y

83.33 %

Q1 2026

Net Margin

16.62 %

Q1 2026

Key Findings: Billiontoone Inc vs Its Competitors

Scale: Billiontoone Inc ranks #12 of 47 companies by market capitalization in the Medical Laboratories industry, holding 1.9% of industry market cap.
Peer revenue share: Billiontoone Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BLLN Sales vs. its Competitors, Q1 2026

Billiontoone Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/BLLN/competitors                    

                        https://api.csimarket.com/api/v1/companies/BLLN/relationships                    

                        https://api.csimarket.com/api/v1/companies/BLLN/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

For context: the Medical Laboratories industry grew revenue 5.7% year over year, combined, vs 83.3% for Billiontoone Inc. Billiontoone Inc's share of combined industry revenue moved from 0.11% to 0.19%, a gain of 0.08 percentage points.

Billiontoone Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Billiontoone Inc	-	-	-	Yes
High-Confidence Competitors (2)
Similar-Size Competitors (10)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

BLLN Stock Performance relative to its Competitors

BLLN Competitors (weighted) Percent change over the selected range

Billiontoone Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

High-Confidence
(1 of 2)

Similar-Size
(7 of 10)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Billiontoone Inc	-	-
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (2)	40.4%	63.2%
Similar-Size Competitors (10)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Billiontoone Inc's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

BLLN Stock Performance relative to High-Confidence Competitors

BLLN High-Confidence Competitors (equal-weighted, 2) Percent change over the selected range

BLLN Stock Performance relative to Similar-Size Competitors

BLLN Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Billiontoone Inc's Comment on Competition and Industry Peers

The company operates in the prenatal testing market with its UNITY product, which addresses comprehensive prenatal genetic needs through a single maternal blood draw. While some competitors have introduced non-invasive prenatal tests (NIPTs) for recessive conditions, the company cites its smNGS technology and accumulated data as competitive advantages. In oncology, the company launched two pan-cancer liquid biopsy tests, Northstar Select and Northstar Response, in 2023. Northstar Select demonstrated higher sensitivity than leading competitors by detecting a greater number of actionable solid tumor mutations. The company identifies its patented smNGS platform and proprietary technologies as key differentiators. Additionally, it utilizes an innovative organizational structure and artificial intelligence to enhance productivity. A head-to-head concordance study submitted during the MolDX evaluation confirmed Northstar Select's superior sensitivity in detecting single nucleotide variants and copy number variants compared to leading competitors.

Billiontoone Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.

Competitor	Basis	Confidence	Active	Sources
Caris Life Sciences Inc	Named by the company	85%	2022 to 2026	3
Natera Inc	Named by the company	85%	2022 to 2026	3

Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Billiontoone Inc's named competitors require a Commercial License.